Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
McKinsey
Dow
Express Scripts
Baxter

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

Drug Master Files for: atazanavir

See Plans and Pricing

« Back to Dashboard


atazanavir Drug Master Files

DMF No. Status Type Submission Date Holder Subject
19856 A II 12/6/2006 EMCURE PHARMACEUTICALS LTD ATAZANAVIR SULFATE
20419 A II 3/27/2007 MYLAN LABORATORIES LTD ATAZANAVIR SULFATE
20559 A II 5/18/2007 OLON SPA ATAZANAVIR SULFATE
21967 A II 3/26/2009 CIPLA LTD ATAZANAVIR SULPHATE
23611 A II 4/12/2010 LUPIN LTD ATAZANAVIR SULFATE
>DMF No. >Status >Type >Submission Date >Holder >Subject

Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
McKesson
Boehringer Ingelheim
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.